Pre-surgical evaluation challenges and long-term outcome in children operated on for Low Grade Epilepsy Associated

Evelyn Karina Chávez López1, Javier Aparicio1, Carlos Valera1

  • 1Department of Child Neurology, Epilepsy and Neurophysiology Unit, Member of the ERN EpiCARE, Hospital Sant Joan de Dèu, Passeig Sant Joan de Déu, Barcelona, Spain.

Insights

Epilepsy surgery is a safe and effective treatment for children with Low-grade Epilepsy Associated brain Tumors (LEATs), leading to seizure control and improved neurocognitive function. Comprehensive pre-surgical evaluations enhance outcomes, enabling medication discontinuation and better development.

Area of Science:

  • Pediatric Neurosurgery
  • Epileptology
  • Pediatric Neurology

Background:

  • Low-grade Epilepsy Associated brain Tumors (LEATs) are a significant cause of refractory epilepsy in children.
  • Understanding the efficacy of surgical interventions and their impact on neurocognitive outcomes is crucial for treatment planning.

Purpose of the Study:

  • To analyze pre-surgical evaluation methods, surgical outcomes, long-term results, and neurocognitive effects in pediatric patients with LEATs.
  • To compare outcomes between pharmacosensitive and drug-resistant epilepsy groups.

Main Methods:

  • Retrospective observational study of 37 children with LEATs undergoing epilepsy surgery.
  • Minimum follow-up of 12 months.
  • Classification into pharmacosensitive (Group 1, n=8) and drug-resistant (Group 2, n=29) epilepsy groups based on response to antiseizure medications (ASMs).

Main Results:

  • The most common tumors were gangliogliomas (35.1%) and dysembryoplastic neuroepithelial tumors (DNTs, 29.7%), often associated with focal cortical dysplasia (FCD).
  • Extended lesionectomy was the most frequent surgical approach (43.2%).
  • At 1-year follow-up, 97.2% achieved Engel Class I seizure control. ASMs were discontinued in 100% of the pharmacosensitive group vs. 34.5% of the drug-resistant group (p=0.002). Significant improvement in verbal comprehension index was observed in the pharmacosensitive group (p=0.029).

Conclusions:

  • Epilepsy surgery is a safe therapeutic option for LEATs, including in children with seizures controlled by ASMs.
  • Comprehensive pre-surgical evaluation improves seizure control, facilitates early discontinuation of ASMs, and promotes neurocognitive development.
  • Associated lesions are common in LEATs, underscoring the need for thorough pre-surgical assessment.
Abstract